Request Dataset
Contact us
Sign in
Lookup
HS API
Service Map
Crosswalk
Validation
Products
Prior Authorization
Businesses
Data Library
CMS Forms
Home
Healthcare Lookup Services
HCPCS Codes Lookup
M1485 | Similar
HCPCS Codes Similar to M1485
HCPCS Codes Similar to “M1485” Code.
Patients who did not achieve sustained virological response as identified by an hcv rna test (cpt 87522) or (cpt 87521) with a negative/undetectable hcv rna result that occurred 20 weeks to 12 months after the first positive/detectable hcv rna test result within the denominator identification period
M1483
Patients who achieve sustained virological response as identified by an hcv rna test (cpt 87522) or (cpt 87521) with a negative/undetectable hcv rna result that occurred 20 weeks to 12 months after the first positive/detectable hcv rna test result within the denominator identification period
Code added date
: 20260101
Code effective date
: 20260101
TXT
|
PDF
|
XML
|
JSON
M1482
Positive/detectable hepatitis c virus quantitative or qualitative rna test result during the denominator identification period
Code added date
: 20260101
Code effective date
: 20260101
TXT
|
PDF
|
XML
|
JSON
C1739
Tissue marker, uniquely detectable and identifiable with probe/sensor, any method (implantable), with delivery system
Code added date
: 20250101
Code effective date
: 20251001
TXT
|
PDF
|
XML
|
JSON
G9400
Documentation of medical or patient reason(s) for not discussing treatment options; medical reasons: patient is not a candidate for treatment due to advanced physical or mental health comorbidity (including active substance use); currently receiving antiviral treatment; successful antiviral treatment (with sustained virologic response) prior to reporting period; other documented medical reasons; patient reasons: patient unable or unwilling to participate in the discussion or other patient reasons
Code added date
: 20150101
Code effective date
: 20220101
TXT
|
PDF
|
XML
|
JSON
M1235
Documentation or patient report of hcv antibody test or hcv rna test which occurred prior to the performance period
Code added date
: 20240101
Code effective date
: 20240101
TXT
|
PDF
|
XML
|
JSON
C9093
Injection, ranibizumab, via sustained release intravitreal implant (susvimo), 0.1 mg
Code added date
: 20220401
Code effective date
: 20220701
TXT
|
PDF
|
XML
|
JSON
G9625
Patient sustained bladder injury at the time of surgery or discovered subsequently up to 30 days post-surgery
Code added date
: 20160101
Code effective date
: 20190101
TXT
|
PDF
|
XML
|
JSON
G9628
Patient sustained bowel injury at the time of surgery or discovered subsequently up to 30 days post-surgery
Code added date
: 20160101
Code effective date
: 20190101
TXT
|
PDF
|
XML
|
JSON
G9631
Patient sustained ureter injury at the time of surgery or discovered subsequently up to 30 days post-surgery
Code added date
: 20160101
Code effective date
: 20230101
TXT
|
PDF
|
XML
|
JSON
S0106
Bupropion hcl sustained release tablet, 150 mg, per bottle of 60 tablets
Code added date
: 20020401
Code effective date
: 20020401
TXT
|
PDF
|
XML
|
JSON
G9511
Index event date phq-9 or phq-9m score greater than 9 documented during the twelve month denominator identification period
Code added date
: 20160101
Code effective date
: 20190101
TXT
|
PDF
|
XML
|
JSON
G9572
Index date phq-score greater than 9 documented during the twelve month denominator identification period
Code added date
: 20160101
Code effective date
: 20170101
TXT
|
PDF
|
XML
|
JSON
M1340
Index assessment completed using the 12-item whodas 2.0 or sds during the denominator identification period
Code added date
: 20240101
Code effective date
: 20240101
TXT
|
PDF
|
XML
|
JSON
M1450
Patients who received hospice or palliative care service any time during denominator identification period or the measure assessment period
Code added date
: 20260101
Code effective date
: 20260101
TXT
|
PDF
|
XML
|
JSON